• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Aulos Raises $20M in Series A Extension Financing From Apple Tree Partners

    BUSINESSWIRE

    Inovio prunes headcount again; Aulos adds to Series A

    ENDPTS

    Interim Results From Phase 1/2 Clinical Trial in Solid Tumor Cancers Demonstrate Aulos Bioscience’s AU-007 is Well Tolerated

    BUSINESSWIRE

    Aulos Bioscience begins US subject dosing in solid tumours therapy trial

    CLINICAL TRIALS ARENA

    Aulos Presents Initial Data From First-in-Human Ph 1/2 Clinical Trial AU-007

    BUSINESSWIRE

    Aulos to Present Data From Ph1/2 Trial of IL-2 Therapeutic AU-007 at SITC

    BUSINESSWIRE

    Aulos Bioscience Presents Poster on Phase 1/2 Clinical Trial of AU-007

    BUSINESSWIRE

    Aulos Bioscience Initiates PI/II Trial of AU-007 for Solid Tumors

    BUSINESSWIRE

    Aulos to Present First-in-Human Phase 1/2 Trial of AU-007 at ASCO

    BUSINESSWIRE

    Aulos obtains approval to start Phase I/II trial for solid tumour asset

    CLINICALTRIALSARENA

    Aulos to Present Preclinical Data on Computationally Evolved IL-2 hAb AU-007

    BUSINESSWIRE

    Aulos Bioscience Appoints Aron Knickerbocker as CEO

    PRNEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.